ATA News Release 2007

Ian Hay, MD, PhD, Elected to Board of Directors of the American Thyroid Association

Nov. 16, 2007—Ian D. Hay, MD, PhD, of Rochester, Minn., has been elected as a director on the board of the American Thyroid Association (ATA). He will serve a four-year term of office (2007–2011).

Dr. Hay, who received his medical and doctorate degrees from the University of Glasgow in Scotland, is a professor of medicine and the Dr. Richard F. Emslander Professor of Endocrinology Research at the Mayo Clinic College of Medicine in Rochester, Minn. He has been a consultant in the Division of Endocrinology, Metabolism, Nutrition and Internal Medicine at the Mayo Clinic since 1983.

Dr. Hay has been an ATA member since 1980. He is a corresponding ETA member and an honorary LATS member. Since 1984, Dr. Hay has served on the ATA Education, Finance and Audit, Nominating and numerous Program Committees. He has chaired the Thyroid Function Testing Committee and the Education Committee, and was the first CMES coordinator in 2001–2002. Dr. Hay was the recipient of the Paul Starr Award in 1994 and previously served as a director on the board of directors from 1995–1999.

Dr. Hay has been involved in thyroid research since 1974 and has given presentations to the ETA, ATA and ITC on an annual basis from 1976 through 2007. His early interests ranged from the effects of prenatal iodine deficiency on fetal brain development, through dyshormonogenesis, to the metabolism and stereospecific detection of dextrothyroxine.

Since his return from Edinburgh to the Mayo Clinic in 1983, Dr. Hay’s daily work has been devoted to “finding answers for patients with thyroid cancer.” He has a particular interest in papillary thyroid cancer and has published extensively in this area since 1986. Dr. Hay wrote the original AACE clinical practice guidelines for the management of thyroid carcinoma in 1997.

In his candidate statement, Dr. Hay expressed his determination to “ensure that patients with thyroid malignancy get the best possible advice from their caregivers who are ATA clinician-members.”

For more information, please contact ATA Communications Consultant Jennifer Reising at (703) 300-9248 or jreising@reisingcommunications.com.